Q-omics provides the consensus-scored RNU6-965P profile across patient tissues and cancer cell-line models. RNU6-965P expression is associated with patient survival in 6 of 34 cancer types, with the highest sampling consensus in STAD. Additionally, RNU6-965P RNA expression shows 4,556 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight STAD as cancer lineages where RNU6-965P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for RNU6-965P — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes RNU6-965P survival associations across molecular data types. RNU6-965P RNA expression shows survival associations in the most cancer types (6). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

RNU6-965P data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	6	STAD (90)	view →

This table ranks reproducible RNU6-965P RNA expression–survival associations across cancer types. High RNU6-965P expression shows unfavorable associations in STAD, ESCA, BRCA, KIRC, GBM and SARC. The STAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify STAD as the clearest survival context for RNU6-965P RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	IV	0.052	0.496	<.001	90	view →
ESCA	OS	Tertile	All	0.198	0.872	.003	36	view →
BRCA	OS	Tertile	All	0.102	0.578	.025	36	view →
KIRC	DFS	Tertile	IV	0.204	0.623	.011	36	view →
GBM	DFS	Tertile	All	0.052	0.257	.002	18	view →
SARC	DFS	Tertile	All	0.207	0.612	.045	9	view →

Pink = unfavorable, green = favorable. all 6 lineages →

RNU6-965P-STAD (OS)

Kaplan–Meier survival curve for RNU6-965P RNA expression in STAD: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with RNU6-965P in patient tissues and cancer cell lines. In patient samples, RNU6-965P shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Function (RNA)	4,556	STAD (3302)	view →
RNA	3,535	ESCA (1944)	view →